SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-097740
Filing Date
2016-02-17
Accepted
2016-02-17 17:00:42
Documents
3
Period of Report
2016-02-10
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-4752_18k.htm 8-K 39722
2 EX-10.1 a16-4752_1ex10d1.htm EX-10.1 89438
3 EX-10.2 a16-4752_1ex10d2.htm EX-10.2 8923
  Complete submission text file 0001104659-16-097740.txt   139661
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 161434097
SIC: 2834 Pharmaceutical Preparations